Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Dr. Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Dr. Faheem Arshad is an Assistant Professor of Neurology at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru. A leading cognitive neurologist in India, he specializes in dementia and neurodegenerative disorders. He played a pivotal role in establishing India’s first cognitive disorders registry at NIMHANS, integrating clinical and research excellence. Dr. Arshad is a Senior Atlantic Fellow for Equity in Brain Health at the University of California, San Francisco (UCSF), and the first fellow from South Asia. His research integrates neurogenetics, biomarkers, imaging, and clinical trials, with a focus on inclusivity and low-literacy populations. He actively contributes to national and international collaborations and holds leadership roles within Indian and global neurology communities. Committed to early diagnosis, caregiver support, and prevention strategies, his work aims to improve brain health equity in diverse settings. His ongoing studies explore social interaction, bilingualism, and digital tools in dementia management.

Profile

Education 🎓

Dr. Arshad received his foundational training in Internal Medicine (MD, 2014) at Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Kashmir. He served as Registrar in Internal Medicine at AIIMS, New Delhi until 2016. He pursued advanced neurological training at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, earning a DM in Neurology (2019) and completing a Post-Doctoral Fellowship in Cognitive Neurosciences (2020). He furthered his expertise with a prestigious international fellowship in Global Brain Health Equity at the Global Brain Health Institute (GBHI), University of California, San Francisco (UCSF), USA in 2021. Dr. Arshad also holds the MRCP(UK) Neurology credential (2020), reflecting global competence. His multidisciplinary training spans cognitive neurology, imaging, biomarkers, and dementia prevention, equipping him with a holistic approach to brain health research and patient care.

Experience 👨‍🏫

Dr. Faheem Arshad’s professional journey spans over a decade of clinical, academic, and research excellence. He is currently Assistant Professor of Neurology at NIMHANS, Bengaluru, where he has led initiatives in cognitive neurology since 2021. His early training included roles as Junior and Senior Resident in Internal Medicine at SKIMS and AIIMS, followed by Neurology Residency and Postdoctoral Fellowship at NIMHANS. He became a faculty leader and Convener of the Cognitive Neurology subsection of the Indian Academy of Neurology in 2023. Internationally, he served as an Atlantic Fellow at UCSF’s GBHI (2020–2021), developing leadership in brain health equity. Dr. Arshad is a member of the American Academy of Neurology and other prestigious forums. He has published widely, initiated clinical trials, and built registries that bridge clinical insights with translational research. His work integrates social science, neurobiology, and global health in addressing dementia across underserved populations.

Awards & Recognitions 🏅

Dr. Faheem Arshad has received numerous recognitions for his contributions to neurology and dementia research. He was awarded the Bursary Award at the TSS International Neuropsychiatry Conference (2018) for his work on social cognition in Frontotemporal Dementia. As the first South Asian to become a Senior Atlantic Fellow for Equity in Brain Health at UCSF’s GBHI, he has been globally recognized for championing equity in dementia care and research. His appointment as Convener of the Cognitive Neurology subsection by the Indian Academy of Neurology in 2023 highlights his leadership within the national academic community. He holds the MRCP(UK) in Neurology and is an active member of prestigious societies, including the American Academy of Neurology. These honors reflect his ongoing commitment to research innovation, community-based care models, and international collaboration in the field of neurodegenerative disorders.

Research Interests 🔬

Dr. Faheem Arshad’s research focuses on dementia, particularly Frontotemporal Dementia (FTD), Alzheimer’s Disease, and related neurodegenerative conditions. He investigates cognitive reserve, biomarkers, social cognition, neuroimaging, and bilingualism in dementia resilience. His landmark projects include exploring the role of social interaction in FTD (GBHI-AA), plasmapheresis in Alzheimer’s (ICMR), cognitive testing in low-literacy settings, and bilingualism’s impact on cognitive reserve (NIH-funded). He co-leads a SERB-funded project using speech features for early dementia detection and a DBT-funded imaging study for vascular dementia diagnosis. He established India’s first cognitive disorders registry at NIMHANS, integrating socio-demographics, imaging, and biomarker data. His work bridges clinical neurology and public health, emphasizing inclusive research for underrepresented populations. A strong advocate for clinical trials in LMICs, his studies integrate AI tools, cross-cultural data, and longitudinal analyses to improve early diagnosis and therapeutic strategies in dementia care.

Publications

Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

Dr. Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

El Dr. Lucas Muñoz-López 🎓 es logopeda neurológico especializado en rehabilitación logopédica en daño neurológico 🧠, con amplia experiencia clínica y académica 👨‍🏫. Tras graduarse en Logopedia por la Universidad de Granada en 2015, combinó práctica profesional y formación de posgrado, incluyendo dos másteres y un doctorado con mención Cum Laude 🏅. Ha ejercido como docente universitario en Melilla y Ceuta, y colabora en investigación con publicaciones en revistas como Frontiers in Psychology 📖. Además, ha tutorizado numerosos TFG y TFM 🎓. Su trabajo integra logopedia clínica, investigación sobre alteraciones de la comunicación y neurociencias, aportando al avance académico y a la rehabilitación de pacientes. Es autor de un libro publicado y miembro activo en proyectos de evaluación y tratamiento en contextos educativos y sanitarios 🏥. Su pasión por la docencia y la terapia lo posiciona como referente en logopedia clínica e investigación 📈.

Profile

Education 🎓

Dr. Muñoz-López 🧠 inició su carrera académica con el Grado en Logopedia (2015) en la Universidad de Granada 🎓, complementándolo ese mismo año con un Máster en Logopedia Clínica en Daño Cerebral (Isep Clinic, Madrid) 💡. En 2017 completó su segundo máster en Neurociencias Básicas y Aplicadas y Dolor en la Facultad de Medicina de Granada 🔬. Culminó su formación con un Doctorado en Psicología y Logopedia en la Universidad de Granada (2021) con mención Cum Laude 🏅, convirtiéndose en experto en alteraciones de la comunicación y rehabilitación neurológica 🧬. Su formación académica combina sólidos conocimientos clínicos, teóricos y metodológicos para abordar con éxito la intervención logopédica y la investigación científica 🏛️. Además, su trabajo refleja una constante actualización y compromiso con la excelencia educativa y terapéutica 💯.

Experience 👨‍🏫

Desde 2015, el Dr. Muñoz-López 🩺 ha desarrollado una sólida trayectoria profesional como logopeda clínico, combinando práctica asistencial con docencia universitaria 👨‍🏫. Ha ejercido en el Centro de Valoración y Orientación de Granada como Auxiliar Técnico en Logopedia 🏥, además de impartir clases en los campus de Ceuta y Melilla de la Universidad de Granada 📚. Ha sido tutor de TFG y TFM en varias universidades, incluyendo la Universidad de Granada y la Universidad Internacional de La Rioja ✍️. Su experiencia docente abarca asignaturas de logopedia, neuropsicología y psicopedagogía en grados y másteres universitarios 🎓. Además, colabora activamente en proyectos de intervención educativa, rehabilitación y formación de futuros profesionales. Su enfoque multidisciplinar y experiencia en contextos clínicos y penitenciarios 🏛️ le permiten aplicar soluciones eficaces e innovadoras en su área.

Awards & Recognitions 🏅

Dr. Muñoz-López ha recibido mención Cum Laude 🎖️ por su tesis doctoral en Psicología y Logopedia en la Universidad de Granada (2021) 🏅. Su tesis fue publicada como libro 📗, reafirmando su valor académico. Ha logrado publicar en la revista Frontiers in Psychology (Q2, JCR 2.99) 🧠, destacándose en el área de psicología y neurociencias. También ha publicado en la revista Journal for Educators, Teachers and Trainers, indexada en bases relevantes como Scopus y Dialnet 📖. Su libro fue editado por la Editorial Académica Española, con índice ICEE de 0.299 📘. Estos reconocimientos consolidan su reputación científica, reflejando la calidad y relevancia de su producción académica, así como su compromiso con la excelencia investigadora y docente 🧑‍🔬✨.

Research Interests 🔬

El Dr. Muñoz-López centra su investigación en la rehabilitación logopédica de alteraciones de la comunicación 🗣️, disfagia 🥄 y terapia miofuncional 💪, con especial atención a contextos neurológicos y penitenciarios 🏛️. Su trabajo profundiza en la intersección entre neurociencias, psicología y logopedia 🧠, explorando tanto enfoques clínicos como educativos. Ha contribuido al avance del conocimiento en alteraciones del lenguaje, evaluación cognitiva y técnicas de intervención para pacientes con daño cerebral adquirido 🧬. Además, participa en estudios sobre integración social, intervención educativa en contextos de riesgo y psicología forense ⚖️. Su enfoque combina metodología cuantitativa, intervención basada en evidencia y aplicación clínica, orientado siempre a mejorar la calidad de vida de las personas con trastornos de la comunicación 💬💡.

Publications
  • Validation and Spanish Adaptation of the Resilience Scale ER-23 in a University Population

    Healthcare
    2025-04-12 | Journal article
    CONTRIBUTORS: Isabel Ramírez-Uclés; Julia Otero; F. Pablo Holgado-Tello; Lucas Muñoz-López; María B. Sánchez-Barrer
  • Analysis of writing in personality disorders in prison population

    Frontiers in Psychiatry
    2024 | Journal article
    EID:
    Part ofISSN: 16640640
    CONTRIBUTORS: Muñoz-López, L.; Fernández-García-Valdecasas, B.; López-Rodríguez, S.; Sánchez-Barrera, M.B.
  • Transformation of Higher Education: Discussion of the Dimensions, Trends and Scenarios of Change in Ibero-America

    Education Sciences
    2024 | Journal article
    Part ofISSN: 22277102
    CONTRIBUTORS: Fernández Cruz, M.; Fernández García Valdecasas, B.; Muñoz López, L.; López Rodríguez, S
  • Associations of Reversal Learning Performance With Personality Disorder Profile and Drug Abuse History in a Sample of Prison Inmates

    2024-09-18 | Journal article
    CONTRIBUTORS: Raquel Martín-Ríos; José C. Perales; Francisca López-Torrecillas; Lucas Muñoz Lóp

Alaa Abd-Elsayed | Neuromidulation | Best Researcher Award

Dr. Alaa Abd-Elsayed | Neuromidulation | Best Researcher Award

Dr. Alaa Abd-Elsayed 🇺🇸 is an American board-certified anesthesiologist and pain medicine specialist at the University of Wisconsin-Madison 🏥, recognized for his leadership, groundbreaking research 🔬, and compassionate patient care 💉, with a prolific academic career as a professor, director, and global speaker 🎤, blending clinical excellence, innovation, and education 📚 in pain management, with over two decades of medical service and leadership roles across Egypt 🇪🇬 and the U.S. 🇺🇸, while holding numerous prestigious certifications 🏅, published research, and leadership awards 🏆, he stands as a dedicated pioneer in improving chronic pain therapy 🔥 and anesthesiology practice worldwide 🌍.

Profile

Education 🎓

Dr. Alaa’s academic journey began at Assuit University 🇪🇬, earning his MBBCh 🩺 in 2000 & MPH 🎓 in 2006; postgrad, he trained extensively in the U.S. 🇺🇸, completing internships, anesthesiology residency, and a pain medicine fellowship 🏥 at the University of Cincinnati 🎯, and a Clinical Research Fellowship at Cleveland Clinic 🧪; board-certified in anesthesiology & chronic pain medicine 💊, and a Certified Physician Executive (CPE) 🏆, he capped his academic prowess with an Executive MBA 🎓 in 2023, mastering both medicine & healthcare leadership 🧠, and attending diverse leadership programs 💼 from AAPL, UW Health, and Faulkner University, cementing a strong foundation in clinical care and strategic innovation ⚡.

Experience 👨‍🏫

With over 20 years in medicine 🩺, Dr. Alaa has held roles from intern 👨‍⚕️ in Egypt 🇪🇬 to Associate Professor 📖, First Division Chief, and Medical Director at UW-Madison 🇺🇸; he’s led UW Health Pain Services 🔥, pioneering chronic pain medicine management 💊; his journey spanned positions at Assuit University, Cleveland Clinic, and University of Cincinnati 🏥; he’s served as chief fellow, staff anesthesiologist, researcher 🔬, educator 📚, and leader, combining advanced clinical practice 🏆 with administrative excellence 💼, mentoring future physicians while driving cutting-edge research 🚀 and pain medicine innovations 🌟.

Awards & Recognitions 🏅

Dr. Alaa’s distinguished career is crowned with awards 🌟 like the Raj/Racz Excellence Award 🥇, Physician of the Year 🏅, America’s Top Doctors 👏, Fellow of ASA 🧠, and recognition as a World Expert 🌍 in pain by Expertscape; multiple top research, poster 🖼️, and abstract prizes 🧾 from ASIPP, MARC, ASPN, ASA, INS & WSA 🏆 highlight his prolific contributions, while his books 📚 were ranked among the best in anesthesiology and pain medicine 💊; his research has shaped clinical practices 🌡️ and his leadership has been applauded across national and global stages 🎤, underlining his impact as a clinician, educator, and thought leader 💡.

Research Interests 🔬

Dr. Alaa’s research explores pain management innovation 🔥, neuromodulation ⚡, spinal cord stimulation 🧠, dorsal root ganglion therapies 💉, and anesthesiology outcomes 🧾; he’s passionate about translating bench-to-bedside discoveries 🏥, optimizing patient-centered chronic pain therapies 💊, and advancing perioperative safety 🌡️; his peer-reviewed publications 📚, clinical trials 🧪, and systematic reviews ⚗️ have influenced global practices 🌍, securing his place among top 0.05% scholars worldwide 🏆; his scientific vision combines clinical evidence, bioethics, and real-world health solutions for pain relief and anesthetic care 🧠💡.

Publications 

Jolanta Dorszewska | Neurobiology | Women Researcher Award

Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award

Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland 🧠🇵🇱. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases 🧬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimer’s and Parkinson’s disease 🧪. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters 📚. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies 🌍.

Profile

Education 🎓

Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 🏅. She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 🧪. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 🎓. Her academic growth includes training in medical genetics from 2012 to 2020 🧬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence 💡.

Experience 👨‍🏫

Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS 👩‍🔬. She was a Research Scientist in New York (1999–2000) 🗽 and has led the Laboratory of Neurobiology since 2004 🧠. She became Full Professor in 2022 🏛️. She also lectured at the National High Medical School in Pila (2012–2018) 📖. Her career blends hands-on research, global collaboration, and dedicated academic leadership 📚. She continues to mentor, publish, and drive innovations in neurology and neurochemistry 🚀

Awards & Recognitions 🏅

Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) 🌐. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research 📘. A section and associate editor for journals across the USA, UK, and Poland 🌍, she’s a key figure in scientific publishing 🖋️. She’s affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books 📚.

Research Interests 🔬

Research Focus:
Her research spans lipid metabolism in hypoxia 🧫, cerebral sterols 🧠, neurotransmitters (serotonin, dopamine) 🧪, apoptosis in aging and disease (Alzheimer’s, Parkinson’s) 💔, and gene polymorphisms (MTHFR, MAO-B, PARK) 🧬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration 🧠. Since 2009, she’s focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics ⚙️. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry 🔍. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases 🚀.

Publications 
  • Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson’s disease

    IBRO Neuroscience Reports
    2025-06 | Journal article
    CONTRIBUTORS: Jolanta Dorszewska; Jolanta Florczak-Wyspiańska; Bartosz Słowikowski; Wojciech Owecki; Oliwia Szymanowicz; Ulyana Goutor; Mateusz Dezor; Paweł P. Jagodziński; Wojciech Kozubski
  • Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

    Sclerosis
    2025-04-03 | Journal article
    CONTRIBUTORS: Katarzyna Wiszniewska; Małgorzata Wilk; Małgorzata Wiszniewska; Joanna Poszwa; Oliwia Szymanowicz; Wojciech Kozubski; Jolanta Dorszewsk
  • Unraveling the Role of Proteinopathies in Parasitic Infections

    Biomedicines
    2025-03-03 | Journal article
    CONTRIBUTORS: Mikołaj Hurła; Damian Pikor; Natalia Banaszek-Hurła; Alicja Drelichowska; Jolanta Dorszewska; Wojciech Kozubski; Elżbieta Kacprzak; Małgorzata Paul
  • Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine

    International Journal of Molecular Sciences
    2025-02-14 | Journal article
    CONTRIBUTORS: Małgorzata Anna Lewandowska; Agata Różycka; Teresa Grzelak; Bartosz Kempisty; Paweł Piotr Jagodziński; Margarita Lianeri; Jolanta Dorszewska

Tran Chau My Thanh | Neuroscience | Young Scientist Award

Dr. Tran Chau My Thanh | Neuroscience | Young Scientist Award

Dr. Tran Chau My Thanh, a dedicated researcher at Duy Tan University, Vietnam 🇻🇳, holds a medical degree and Ph.D. from Hue University of Medicine and Pharmacy 🎓. Her work bridges the gap between clinical medicine and molecular biology 🧬. With a strong passion for translational research, she focuses on using bioinformatics and genomic tools for early diagnosis and targeted therapy development for diseases like cancer, diabetes, and cardiovascular disorders 💉. Through CRISPR/Cas9 and RNA networks, she aims to revolutionize patient-specific treatment pathways 🚀. Her extensive lab experience, scholarly publications, and ongoing innovations make her a promising leader in biomedical science 🏅.

Profile

Education 🎓

Dr. Thanh earned her Medical Degree (M.D.) from Hue University of Medicine and Pharmacy 🏥 and went on to complete her Doctorate (Ph.D.) in the same prestigious institution 🎓. Her education was deeply rooted in both clinical and research training, equipping her with a comprehensive understanding of human health and disease 🧠. Throughout her academic journey, she focused on genomics, molecular medicine, and biotechnology 🔬. The rigorous curriculum and hands-on exposure in advanced labs trained her in modern diagnostic tools and therapeutic innovations ⚙️. She also mastered computational biology and molecular interactions, forming a solid foundation for her groundbreaking work in RNA regulation and gene editing technologies such as CRISPR/Cas9 🧪.

Experience 👨‍🏫

Dr. Thanh brings rich experience as a medical doctor and academic at Duy Tan University 🏫. Her research career spans multiple roles in molecular diagnostics, bioinformatics, and therapeutic innovation 🧬. She has led studies on disease biomarkers, participated in international collaborations 🌐, and worked extensively with cell lines, recombinant DNA, and next-gen sequencing data 🔍. Her proficiency in wet lab and dry lab environments empowers her to integrate experimental biology with computational modeling 🧫💻. Alongside mentoring students and publishing SCI-indexed research, she contributes to translational medicine by connecting bench science to bedside applications, helping advance precision medicine for critical illnesses 💡.

Awards & Recognitions 🏅

Dr. Thanh is a nominee for the Young Scientist Award by the International Cognitive Scientist Awards 🧠🏆. Her impactful work on circular RNAs, miRNAs, and disease biomarker networks has garnered international recognition 🌍. She’s been acknowledged in high-impact journals for discoveries related to coronary heart disease and cancer diagnostics 📖. Her scholarly articles are indexed in SCI and Scopus, and she continues to influence the biomedical community through conference presentations, peer reviews, and academic collaborations 🤝. As a rising figure in molecular biology, her research promises transformative outcomes for early disease detection and targeted therapies 🧬✨.

Research Interests 🔬

Dr. Thanh’s research explores circRNA/miRNA/mRNA interactions, protein-protein networks, and gene function analysis 🧬🧠. She is driven by the quest to discover novel biomarkers for early diagnosis of complex diseases such as cancer, stroke, and diabetes 💊. Her focus includes CRISPR/Cas9 gene editing, molecular docking, and simulations for drug discovery and target validation 💻🧪. She also builds interaction networks to map LncRNA/CircRNA/miRNA/gene/protein-drug relationships, contributing to personalized medicine approaches 🎯. Through bioinformatics, she decodes gene expression dynamics and immune infiltrations to enable efficient diagnostics and therapeutics 💡. Her ultimate goal is to bridge computational biology with translational research for global health improvement 🌐💚.

Publications 

1. Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression
by sponging miRNA-338-3p via regulating the expression of ETS1
2. Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as
potential biomarker for coronary heart disease
3. Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of
bioinformatics data

Elsa Pittaras | Neuroscience | Women Researcher Award

Dr. Elsa Pittaras | Neuroscience | Women Researcher Award

Elsa Pittaras is a Basic Life Research Scientist at Stanford University, specializing in neuroscience, cognition, and sleep research. With expertise in molecular biology, neuroanatomy, pharmacology, and behavior, she has extensively studied decision-making processes in mice. Her research has contributed significantly to understanding sleep deprivation’s effects on cognition and memory in Down Syndrome and Alzheimer’s disease models. She has published multiple papers as both first and last author, showcasing her leadership in neuroscience. Elsa’s goal is to advance research on mood disorders, cognition, and neurochemistry, aspiring to become an independent researcher in the U.S. 🇺🇸🔬🧠

Profile

Education 🎓

Elsa Pittaras earned a B.S. in Physiology from the University of Caen (2010), an M.S. in Neuroscience from the University of Paris Sud and ENS Cachan (2012), and a Ph.D. in Neuroscience from Neuro-PSI and the Biomedical Research Unit of the French Army (2016). Her multidisciplinary foundation in biology, physics, chemistry, and mathematics from Châtelet, Douai (2009) laid the groundwork for her neuroscience expertise. Throughout her education, she focused on decision-making, sleep deprivation, and neurochemical mechanisms in cognition. 🧠📚🎓

Experience 👨‍🏫

Elsa Pittaras has been a Basic Life Research Scientist at Stanford University since 2022, focusing on cognitive enhancement in Down Syndrome and Alzheimer’s disease models. She was a Postdoctoral Fellow at Stanford (2017-2022), investigating sleep and circadian rhythms’ effects on memory. Previously, she conducted research at the Biomedical Research Unit of the French Army (2016-2017) and completed her Ph.D. at Neuro-PSI. Her career includes internships in neuroscience at Neuro-PSI (2011-2012) and clinical observations at CHU Caen (2010). 🏛️🧬🧪

Research Interests 🔬

Elsa’s research explores decision-making, memory, and sleep in neurodevelopmental disorders. She pioneered the Mouse Gambling Task, revealing individual decision-making strategies. Her Ph.D. identified neurochemical markers of decision-making behaviors and the effects of sleep deprivation. At Stanford, she investigates sleep’s impact on cognition in Down Syndrome and Alzheimer’s models, aiming to improve memory and sleep quality through pharmacological interventions. Her work bridges behavioral neuroscience with neurochemistry to enhance cognitive function. 🧠💡🛌

Awards & Recognitions 🏅

Elsa has received prestigious grants, including the Jerome Lejeune Research Grants (2019, 2020), the Fyssen Foundation Research Grant (2017), and travel awards for conferences such as T21RS (2021) and Advances in Sleep and Circadian Science (2019). She was also recognized by the French Society for Research and Sleep Medicine (2014) and received a European Neuroscience Federation travel award (2016). 🏅

Publications 

  • Selectively Blocking Small Conductance Ca2+-Activated K+ Channels Improves Cognition in Aged Mice.

  • Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model

  • Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer’s Disease.

  • Inter-individual differences in cognitive tasks: focusing on the shaping of decision-making strategies

  • Handling, task complexity, time-of-day, and sleep deprivation as dynamic modulators of recognition memory in mice

  • Enhancing sleep after training improves memory in down syndrome model mice

 

said Pournaghash-tehrani | Neuroscience | Best Faculty Award

Dr. said Pournaghash-tehrani | Neuroscience | Best Faculty Award

 

Profile

  • Googlescholar
  • Researchgate

Education

Said Pournaghash-Tehrani earned his Doctor of Philosophy in Psychology in 1993 from The American University in Washington, D.C., where he also completed his Master of Arts in Psychology in 1990. He holds a Bachelor of Science in Distributive Science from the same institution, which he obtained in 1986. Fluent in English and German, he also has familiarity with French. He can be reached via email at spournaghash@yahoo.com or by telephone at 011-98-09122074388.

Work experience
  • Said Pournaghash-Tehrani has extensive academic and research experience in psychology. He served as a Research Associate in 2001 at the Department of Pharmacology and Experimental Therapeutics, Loyola University’s Stritch School of Medicine in Chicago, Illinois. In 2002, he took a sabbatical as a researcher at the Department of Psychology, Carleton University in Ottawa, Canada, focusing on cross-cultural studies related to Iranian attitudes towards the West. Since 2002, he has been an Assistant Professor in the Department of Psychology at Tehran University, having previously held the same position at Azzahra University in Tehran from 1996 to 2001. Additionally, he was a member of the Scientific Council on Energy and Economic Studies at the Institute for International and Political Studies (IPIS) from 1998 to 2000, where he also worked as a political researcher. His early academic career included serving as a Teaching and Research Assistant at The American University’s Department of Psychology from 1987 to 1990, where he contributed to courses such as Introduction to Psychology, Neuroscience Seminar, Psychopharmacology, Neuropsychology, Biological Basis of Behavior, and Learning and Behavior.

Books

Fundamentals of Clinical Psychopharmacology, (2007); Samt Publications
-Drugs and Behavior, (2004); Samt Publications.
-Physiological Psychology, Tehran University Publication.
-Intimacy; Alzahra University Publication.
-Theories of Addiction, Alzahra University Publication.

Conference Presentations

Said Pournaghash-Tehrani has contributed extensively to neuroscience and psychology research, presenting his findings at prestigious conferences such as the Society for Neuroscience and the Eastern Psychological Association. His work has focused on drug discrimination learning, conditioned taste aversion, and the effects of opioids and their antagonists. In 1987, he co-authored studies assessing the discriminative stimulus properties of naloxone and the failure of cholecystokinin to counteract morphine sulfate’s effects. His later research explored the antagonism of morphine stimuli, the role of buprenorphine in opiate-naive and dependent animals, and the impact of RO15-4513 on ethanol-induced taste aversion. He has collaborated with notable researchers, including A.L. Riley, contributing to investigations on diazepam exposure and behavioral toxicology. His presentations in New Orleans, Washington, D.C., Boston, and other major research venues highlight his significant role in advancing psychopharmacology and behavioral neuroscience.

Publication